Development of prospective non-toxic inhibitors of ABCB1 activity and expression in a series of selenophenoquinolinones

• DOI: 10.1039/d2nj00340f
• Publication Date: 2022-03-14T19:21:18Z
• Authors: Jelena Vasiljeva; Marina Makrecka-Kuka; Ilona Domracheva; Karlis Vilks; Pavels Dimitrijevs; Pavel Arsenyan
• Keywords: 0301 basic medicine; 03 medical and health sciences; 3. Good health

Selenophenoquinolinone is a prospective scaffold for the development of ABCB1 inhibitors treatment MDR cancers.